Obstructive Sleep Apnea - Chicago IL (Clinical Trial # 14711)
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials. 
| City: |
|
Chicago |
| State: |
|
IL |
| Zip Code: |
|
60634 |
| Study summary: |
|
If you decide to take part in this study you will receive either liraglutide or an inactive drug
(placebo). Placebo is identical in appearance to the active drug but contains no active ingredient.
For this study the term “study drug” refers to both liraglutide and placebo.
This study will assess the effect of a liraglutide-induced weight loss on obstructive sleep apnea.
This study is part of an international program and is planned to take place in Canada and the U.S.
It will include approximately 308 men and women 18 – 64 years of age. |
| Qualified participants must: |
|
• Be 18-64 years of age
•
Suffer from sleep apnea |
| Participants may receive: |
|
You may receive compensation for office visits. |
|
|
|
| Clinic Profile: |
|
View Clinic Profile |
|
Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials or take the Participation Quiz to find out if you are a good candidate for clinical trial participation.